An Interview with Ana Vivancos, PI of VHIO´s Cancer Genomics Group: Biomarker anlayses in emerging data from P13K/AKT/mTOR program clinical trials

At the recent IMPAKT Breast Cancer Conference, 2 – 4th May, Brussels, ecancer´s Peter Goodwin talks to Ana Vivancos about her pioneering research in cancer genomics and work contributing to improved phase I clinical studies and best therapies for patients.

To view the video now click here.

Related Posts